Epigenetic Therapy Shows Promise Against Treatment-Resistant AML
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid leukemia (AML)…
Read the full articleYou might also wanna read
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
New therapy targets Hippo pathway to fight treatment-resistant acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effecti
Immune cells use previously unknown pathway to eliminate acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (A
Researchers uncover new T cell attack mechanism against acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (A
Epigenomic Analysis Reveals 16 New AML Subgroups and Drug Sensitivities
A chromatin-based study of 1,563 AML samples identifies novel epigenomic subgroups that enhance prognostic accuracy and uncover unexpected t
Epigenomic Analysis Uncovers New AML Subgroups and Drug Sensitivities
New chromatin‑based analysis of 1,563 AML samples reveals 16 epigenomic subgroups that improve prognostic accuracy and highlight unexpected
Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes
Clonal hematopoiesis (CH) is the age-related expansion of mutated hematopoietic stem cells without hematologic abnormalities. In patients wi
Comments
Sign in to join the conversation.
No comments yet. Be the first.